|Who We Are|
|Board of Directors|
|Annual Reports and Financials|
|Office of Inspector General Advisory Opinion|
Patrick McKercher appointed president of Patient Access Network Foundation
WASHINGTON, D.C. – The board of directors of the Patient Access Network Foundation is pleased to announce the appointment of its new president, Dr. Patrick McKercher.
McKercher's appointment follows a distinguished career dedicated to the study of patient access issues including significant research of medication therapy procurement barriers. Dr. McKercher has served as PAN's Interim President since March and previously served on PAN's Board of Directors where he provided strategic direction around the anticipated changes in the healthcare environment.
Prior to his roles at PAN, Dr. McKercher held several leadership roles including Executive Director of Corporate Initiatives at The Upjohn Company, Founding Director of the Center for Medication Use, Policy and Economics at the University of Michigan and Executive Director of the Center for Drugs and Public Policy at the University of Maryland at Baltimore. Early in his career, Dr. McKercher was Director of Pharmacy at Muskegon General Hospital in Muskegon, Michigan.
“PAN provides very necessary assistance to patients most likely to abandon therapy because of high out-of-pocket burdens. I am honored to serve as PAN’s president and am committed to increasing the number of underinsured patients we help to access optimum therapies by securing increased funding and continuing our efficient operations,” says McKercher.
"Pat is ideal for this role. As a pharmacist and policy researcher he brings to Patient Access Network an extensive knowledge of patient access issues, copayment assistance, and medication policy," said Lyn Boocock-Taylor, chair of PAN's Board of Directors.
PAN provides financial assistance to underinsured patients through 33 cancer, rare and chronic disease funds that cover conditions such as rheumatoid arthritis, breast cancer, and colorectal cancer. PAN provides grants of $1,500-$15,000 per year to qualified patients to help pay for medications for these diseases. In 2010 PAN helped more than 21,000 patients access appropriate medication therapies.For more information on PAN, go to www.PANfoundation.org